학술논문

Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, March 2024, 73(3))
Subject
Language
English
ISSN
14320851
03407004